MedTrace Logo

Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen

NCT00791973 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-07-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to help us to a better understanding of how nose and eye symptoms are related in patients with allergies.

Conditions

  • Allergic Rhinitis

Interventions

DRUG

fluticasone furoate

2 puffs in each nostril once daily for 1 week

DRUG

Placebo

2 puffs in each nostril once daily for 1 week

Sponsors & Collaborators

Principal Investigators

  • Robert Naclerio, MD · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-04-30
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00791973 on ClinicalTrials.gov